Psychological support in psilocybin therapy?

Compass publishes new “formal & scalable methodology“

$CMPS also has pending patent applications on elements of psilocybin-assisted therapy

Could patents stop others from offering psychological support using their methodology?

1/ https://twitter.com/PsilocybinAlpha/status/1356941056852525057

Compass’ ’688 PCT application claims methods of treating depression by administering psilocybin

They are not limited to use of Compass’ COMP360 psilocybin polymorph A

Would these cover all methods of treating depression with psilocybin?

https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2020212952&tab=PCTBIBLIO

2/

Compass’ ‘688 PCT application claims aspects of “psychological support sessions” before and after administration of psilocybin:

“at least one therapeutic intention is discussed”

“self-directed inquiry and experiential processing are practiced”

https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2020212952&tab=PCTCLAIMS

3/

Compass’ app claims administering psilocybin “in a room with a substantially non-clinical appearance”:

“the room comprises soft furniture"

“the room is decorated using muted colors”

“the room comprises a high-resolution sound system”

“the room comprises a bed or a couch”

4/

Compass’ application claims administering psilocybin:

“wherein the subject lies in the bed or on the couch”

“wherein the subject listens to music”

“wherein the subject wears an eye mask”

5/

Claims cover how “therapist provides psychological support”:

“the therapist uses guided imagery and/or breathing exercises”

“the therapist provides reassuring physical contact”

“the therapist holds the hand, arm, or shoulder”

“the therapist does not initiate conversation”

6/

Compass’ ‘688 PCT application claims are not limited to treatment of depression

Compass also has filed two separate PCT applications

‘948 application: https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2020212948

‘951 application: https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2020212951

7/

Could these patent claims be granted?

Could they be used against therapists?

“We hope that this first step encourages collaboration among therapist training providers, as we work towards bringing psilocybin therapy to all who might benefit”

https://psilocybinalpha.com/news/compass-pathways-announces-publication-in-frontiers-in-psychiatry-of-paper-on-therapist-training-programme-for-psilocybin-therapy

eof/